Diagnosis of von Willebrand disease in South Island, New Zealand

Seminars in Thrombosis and Hemostasis

Volumn 37, Issue 5, 2011, Pages 555-559

  Rajagopal, Rajeev ^a   Smith, Mark P ^a  

^a CANTERBURY HEALTH LABORATORIES   (New Zealand)

Author keywords

diagnostic algorithm; flow cytometry; New Zealand; von Willebrand disease; von Willebrand factor; VWD; VWF function

Indexed keywords

DESMOPRESSIN; RECOMBINANT BLOOD CLOTTING FACTOR 8; TRANEXAMIC ACID; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

COCHRANE LIBRARY; DIAGNOSTIC TEST; FLOW CYTOMETRY; GENETIC SCREENING; HEALTH EDUCATION; HEMOSTASIS; HUMAN; NEW ZEALAND; PREVALENCE; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SUPPORT GROUP; VON WILLEBRAND DISEASE;

CLINICAL LABORATORY TECHNIQUES; DEAMINO ARGININE VASOPRESSIN; GENETIC TESTING; HEMOSTATICS; HUMANS; MUTATION; NEW ZEALAND; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 81755184041     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0031-1281042     Document Type: Review

References (19)

1. Castaman G, Montgomery RR, Meschengieser SS, Haberichter SL, Woods AI, Lazzari MA. von Willebrand's disease diagnosis and laboratory issues. Haemophilia 2010 16 5, Suppl 5 67-73
2. Howard MA, Sawers RJ, Firkin BG. Ristocetin: a means of differentiating von Willebrand's disease into two groups. Blood 1973 41 5 687-690
3. Brown JE, Bosak JO. An ELISA test for the binding of von Willebrand antigen to collagen. Thromb Res 1986 43 3 303-311 (Pubitemid 16060834)
4. Favaloro EJ. An update on the von Willebrand factor collagen binding assay: 21 years of age and beyond adolescence but not yet a mature adult. Semin Thromb Hemost 2007 33 8 727-744 (Pubitemid 351158442)
5. Favaloro EJ, Bonar R, Kershaw G et al, RCPA QAP in Haematology. Reducing errors in identification of von Willebrand disease: the experience of the Royal College of Pathologists of Australasia Quality Assurance Program. Semin Thromb Hemost 2006 32 5 505-513 (Pubitemid 44157389)
6. Vanhoorelbeke K, Cauwenberghs N, Vauterin S, Schlammadinger A, Mazurier C, Deckmyn H. A reliable and reproducible ELISA method to measure ristocetin cofactor activity of von Willebrand factor. Thromb Haemost 2000 83 1 107-113 (Pubitemid 30045485)
7. Federici AB, Canciani MT, Forza I et al. A sensitive ristocetin co-factor activity assay with recombinant glycoprotein Ibalpha for the diagnosis of patients with low von Willebrand factor levels. Haematologica 2004 89 1 77-85 (Pubitemid 38165858)
8. Lindahl TL, Fagerberg IH, Larsson A. A new flow cytometric method for measurement of von Willebrand factor activity. Scand J Clin Lab Invest 2003 63 3 217-223
9. Giannini S, Mezzasoma AM, Leone M, Gresele P. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry. Haematologica 2007 92 12 1647-1654 (Pubitemid 350248244)
10. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986 1 8476 307-310 (Pubitemid 16134762)
11. Denholm A, Smith MP, Patterson DM. Accurate diagnosis of high-affinity VWF-platelet disorders: a case study of pseudo von Willebrand disease. NZ J Med Lab Sci 2008 62 1 7-9 (Pubitemid 351500579)
12. Allan KL, Patterson DM, Smith MP. Validation of a von Willebrand factor-factor VIII binding assay to characterise atypical phenotypes of apparent haemophilia A. NZ J Med Lab Sci 2003 57 1 12-15 (Pubitemid 36547200)
13. Casonato A, Pontara E, Zerbinati P, Zucchetto A, Girolami A. The evaluation of factor VIII binding activity of von Willebrand factor by means of an ELISA method: significance and practical implications. Am J Clin Pathol 1998 109 3 347-352 (Pubitemid 28110580)
14. Goodeve AC. The genetic basis of von Willebrand disease. Blood Rev 2010 24 3 123-134
15. Favaloro EJ, Patterson D, Denholm A et al. Differential identification of a rare form of platelet-type (pseudo-) von Willebrand disease (VWD) from type 2B VWD using a simplified ristocetin-induced-platelet-agglutination mixing assay and confirmed by genetic analysis. Br J Haematol 2007 139 4 623-626 (Pubitemid 350043816)
16. Mancuso DJ, Tuley EA, Westfield LA et al. Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction. Biochemistry 1991 30 1 253-269
17. Bowen DJ. An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13. J Thromb Haemost 2003 1 1 33-40
18. Kokame K, Nobe Y, Kokubo Y, Okayama A, Miyata T. FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol 2005 129 1 93-100 (Pubitemid 40524057)
19. Haemophilia Foundation of New Zealand. Details available at: Haemophilia.org.nz Accessed December 12, 2010